A preprint report utilizing a New York state database of children ages 5-17 analyzed the effectiveness of the Pfizer-BioNTech COVID-19 jab. The researchers estimated the mRNA injection’s efficacy against COVID cases and hospitalizations for the age demographics during December, 2021 and January, 2022. The Abstract states: In the Omicron era, the effectiveness against cases of … Continue reading Pfizer COVID-19 Jab Increases Risk of COVID Infection for 5-11-Year Olds, According to New York State Data